Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels

Arthritis and Rheumatism

Volumn 52, Issue 12, 2005, Pages 3880-3889

  Af Klint, Erik ^a   Grundtman, Cecilia ^a   Engström, Marianne ^a   Catrina, Anca Irinel ^a   Makrygiannakis, Dimitrios ^a   Klareskog, Lars ^a   Andersson, Ulf ^a   Ulfgren, Ann Kristin ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD31 ANTIGEN; CD68 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ETANERCEPT; GLUCOCORTICOID; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE HEXACETONIDE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTHROSCOPY; ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CHRONIC ARTHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE; MALE; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY; BLOOD VESSELS; CYTOKINES; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HMGB1 PROTEIN; HUMANS; INJECTIONS, INTRA-ARTICULAR; MACROPHAGES; MALE; MIDDLE AGED; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; SYNOVITIS; T-LYMPHOCYTES; TRIAMCINOLONE ACETONIDE;

EID: 29144486850     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21488     Document Type: Article

References (35)

1. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol 1996;60:563-72.
2. Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future? [review]. Arthritis Rheum 2002;46:2553-63.
3. Ostergaard M, Stoltenberg M, Gideon P, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone: quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996;23:1151-61.
4. Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum 2004;50:3783-91.
5. Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNF α and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001;3:188-99.
6. Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J Intern Med 2004;255:344-50.
7. Andersson U, Tracey KJ. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheum Dis Clin North Am 2004;30:627-37.
8. Andersson U, Wang H, Aveberger AC, Janson A, Palmblad K, Yang H, et al. High mobility group-1 (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70.
9. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995-1001.
10. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5.
11. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000;275:40096-105.
12. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Ulfgren AK, Grondal L, Lindblad S, Johnell O, Klareskog L, Andersson U. Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis 2000;59:439-47.
15. Seddighzadeh M, Larsson P, Ulfgren AC, Onelov E, Berggren P, Tribukait B, et al. Low IL-1α expression in bladder cancer tissue and survival. Eur Urol 2003;43:362-8.
16. Brink N, Szamel M, Young AR, Wittern KP, Bergemann J. Comparative quantification of IL-1β, IL-10, IL-10r, TNFα and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflamm Res 2000;49:290-6.
17. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004;53:1082-9.
18. Pachot A, Monneret G, Voirin N, Leissner P, Venet F, Bohe J, et al. Longitudinal study of cytokine and transcription factor mRNA expression in septic shock. Clin Immunol 2005;114:61-9.
19. Khademi M, Illes Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, et al. T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169-76.
20. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304-15.
21. Kirsch AH, Mahmood AA, Endres J, Bohra L, Bonish B, Weber K, et al. Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation and ex vivo. J Biol Regul Homeost Agents 1999;13:80-9.
22. Auron PE, Webb AC. Interleukin-1: a gene expression system regulated at multiple levels. Eur Cytokine Netw 1994;5:573-92.
23. Zhang G, Zhang L, Duff GW. A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human IL-1β gene. DNA Cell Biol 1997;16:145-52.
24. Luedke CE, Cerami A. Interferon-γ overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 1990;86:1234-40.
25. Borrman L, Kim I, Schultheiss D, Rogalla P, Bullerdiek J. Regulation of the expression of HMGB1, a co-activator of the estrogen receptor. Anticancer Res 2001;21:301-5.
26. 2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 2001;1:739-54.
27. Muller S, Ronfani L, Bianchi ME. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 2004;255:332-43.
28. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004;10:1216-21.
29. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, et al. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997;40:1400-8.
30. Young L, Katrib A, Cuello C, Vollmer-Conna U, Bertouch JV, Roberts-Thomson PJ, et al. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum 2001;44:343-50.
31. Kirkham BW, Navarro FJ, Corkill MM, Panayi GS. In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1β. J Rheumatol 1994;21:1615-9.
32. Ulfgren AK, Andersson U, Engstrom M, Klareskog L, Maini RN, Taylor PC. Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor a synthesis. Arthritis Rheum 2000;43:2391-6.
33. Ulfgren AK, Grundtman C, Borg K, Alexandersson H, Andersson U, Harris HE, et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 2004;50:1586-94.
34. Lundberg I, Kratz AK, Alexandersson H, Patarroyo M. Decreased expression of interleukin-1α, interleukin-1β, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2000;43:336-48.
35. Zuckerman SH, Shelhaas JS, Butler LD. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 1989;19:301-5.